Clinical trial · Interventional
Hope-Focused Motivational Interviewing in Cancer Patients
Effects of Hope-Focused Motivational Interviewing on Hope, Self-Efficacy, and Self-Compassion in Cancer Patients Undergoing Radiotherapy: A Randomized Controlled Trial
NCT07585838CI-TRIAL-00111615enrolling by invitationN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to examine the effects of hope-focused motivational interviewing on levels of hope, self-efficacy, and self-compassion in patients with cancer receiving radiotherapy, using a randomized controlled design.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Hope | — | UNRESOLVED | — |
| Motivational Intervention | — | UNRESOLVED | — |
| Self-Compassion | — | UNRESOLVED | — |
| Self-Efficacy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hope-Focused Motivational Interviewing | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Experimental
- description
- Participants in the intervention group will receive an individual-based Hope-Focused Motivational Interviewing program consisting of four sessions delivered twice weekly.
- interventionNames
- Behavioral: Hope-Focused Motivational Interviewing
- type
- NO_INTERVENTION
- label
- Control
- description
- Participants in the control group will receive routine care only and will not be exposed to any structured psychosocial intervention during the study period. Data will be collected at the same time points as the intervention group (baseline, post-test, and 1-month follow-up).
Primary outcomes (1)
- measure
- Herth Hope Index
- timeFrame
- Baseline, immediately after the 2-week intervention, and 1 month post-intervention
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Being 18 years of age or older * Having a diagnosis of Stage I-III cancer according to the TNM staging system Receiving radiotherapy at the study center (including adjuvant, neoadjuvant, or definitive RT) * Being in the first week of the radiotherapy process * Being able to read and understand Turkish and communicate at a level sufficient to participate in interviews * Agreeing to attend the intervention sessions at scheduled times and providing written informed consent Exclusion Criteria: * Presence of metastatic disease (Stage IV) or recurrent cancer * Receiving concurrent chemotherapy during the radiotherapy process * Presence of severe psychiatric conditions that may interfere with participation or the safe implementation of the intervention (e.g., psychotic disorders, bipolar disorder in the manic phase, or severe major depression) * Presence of moderate to severe cognitive impairment/dementia, significant attention or concentration problems, or neurological conditions that may compromise the reliability of responses * Severe hearing or speech impairments or communication difficulties that would prevent participation in interviews or completion of questionnaires (if appropriate support cannot be provided) * Participation in another structured psychosocial intervention program (e.g., hope-based, psychoeducational, or psychotherapeutic programs) during the study period
References
Publications (0)
Data not yet available
No reference posted for this study.